Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: A quantitative survey

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Nguyen, Thuy Nhien ^a   Thu, Pham N Huong ^a   Hung, Ngo Trong ^a   Son, Do Hung ^a   Tien, Nguyen Thanh ^a   Van Dung, Nguyen ^b   Quang, Huynh Hong ^c   Seidlein, Lorenz Von ^d,e   Cheah, Phaik Yeong ^d,e   Dondorp, Arjen M ^d,e   Day, Nicholas P J ^d,e   White, Nicholas J ^d,e   Hien, Tran Tinh ^a,e  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Binh Phuoc Malaria Prevention and Control Center   (Viet Nam)

^c Institute of Malariology Parasitology and Entomology (IMPE)   (Viet Nam)

^d MAHIDOL UNIVERSITY   (Thailand)

^e CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Attitude; Knowledge; Malaria; Mass drug administration; Perceptions; Plasmodium falciparum; Plasmodium vivax; Quantitative survey; South East Asia; Vietnam

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROARTEMISININ PLUS PIPERAQUINE; PRIMAQUINE;

COMMUNITY CARE; COMMUNITY PARTICIPATION; HEALTH AUXILIARY; HUMAN; INFECTION PREVENTION; MALARIA; PLASMODIUM FALCIPARUM; QUANTITATIVE STUDY; RANDOM SAMPLE; REVIEW; SOCIAL WELFARE; VIET NAM; ADULT; ATTITUDE TO HEALTH; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; FEMALE; INTERVIEW; MALE; MIDDLE AGED; PATIENT ATTITUDE; PREVENTION AND CONTROL; PROCEDURES; RURAL POPULATION;

ADULT; ANTIMALARIALS; CHEMOPREVENTION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MALARIA; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RURAL POPULATION; VIETNAM;

EID: 85008482428     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1662-2     Document Type: Review

References (24)

1. WHO: Mass drug administration, mass screening and treatment and focal screening and treatment for malaria. Geneva: World Health Organization; WHO/HTM/GMP/MPAC/20159 2015.
2. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
3. von Seidlein L, Greenwood BM. Mass administrations of antimalarial drugs. Trends Parasitol. 2003;19:452-60.
4. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13:715-30.
5. Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NP, et al. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review. Malar J. 2016;15:523.
6. Greenough P. Intimidation, coercion and resistance in the final stages of the South Asian smallpox eradication campaign, 1973-1975. Soc Sci Med. 1995;41:633-45.
7. Watanabe N, Kaneko A, Yamar S, Taleo G, Tanihata T, Lum JK, et al. A prescription for sustaining community engagement in malaria elimination on Aneityum Island, Vanuatu: an application of Health Empowerment Theory. Malar J. 2015;14:291.
8. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
9. Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, et al. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J. 2012;11:355.
10. Lwin KM, Imwong M, Suangkanarat P, Jeeyapant A, Vihokhern B, Wongsaen K, et al. Elimination of Plasmodium falciparum in an area of multi-drug resistance. Malar J. 2015;14:319.
11. Lwin K, Phyo A, Tarning J, Hanpithakpong W, Ashley E, Lee S, et al. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly ihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria. Antimicrob Agents Chemother. 2012;56:1571-7.
12. Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, Day NPJ, et al. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob Agents Chemother. 2008;52:1052-61.
13. Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.
14. Hanboonkunupakarn B, Ashley EA, Jittamala P, Tarning J, Pukrittayakamee S, Hanpithakpong W, et al. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects. Antimicrob Agents Chemother. 2014;58:7340-6.
15. White NJ, Qiao LG, Qi G, Luzzatto L. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012;11:418.
16. Sutanto I, Suprijanto S, Kosasih A, Dahlan MS, Syafruddin D, Kusriastuti R, et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western Indonesia: an open-label, randomized, controlled trial. Clin Infect Dis. 2013;56:685-93.
17. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Trop Med Int Health. 2001;6:442-8.
18. Holman HR. Qualitative inquiry in medical research. J Clin Epidemiol. 1993;46:29-36.
19. Black N. Why we need qualitative research. J Epidemiol Community Health. 1994;48:425-6.
20. Kajeechiwa L, Thwin MM, Shee PW, Yee NL, Elvina E, Peapah P, et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J. 2016;15:494.
21. Dial NJ, Ceesay SJ, Gosling RD, D'Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia. Malar J. 2014;13:47.
22. Dierickx S, Gryseels C, Mwesigwa J, O'Neill S, Bannister-Tyrell M, Ronse M, et al. Factors associated with non-participation and non-adherence in directly observed mass drug administration for malaria in The Gambia. PLoS ONE. 2016;11:e0148627.
23. Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 2007;4:e273.
24. Lavery JV, Tinadana PO, Scott TW, Harrington LC, Ramsey JM, Ytuarte-Nunez C, et al. Towards a framework for community engagement in global health research. Trends Parasitol. 2010;26:279-83.